NCT00165347View on ClinicalTrials.gov

Protein Tyrosine Kinases (PTK) in Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Multiple Myeloma
Interventions
DRUG

PTK787/ZK222584

Trial Locations (1)

02115

Dana-Farber Cancer Institute, Boston

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Novartis

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER